Discover
IDXX
IDEXX Laboratories, Inc.
537.58
1 x 525.94
1 x 532.67
bid
ask
+
11.14
2.12%
1 @ 04:00 PM
544.55 +6.97 (1.30%)
| Ytd | -20.54% | |
| 1y | -0.93% |
528.71
day range
539.09
506.91
52 week range
769.98
| Open | 533.61 | Prev Close | 526.44 | Low | 528.71 | High | 539.09 | Mkt Cap | 42.41B |
| Vol | 647.03K | Avg Vol | 628.85K | EPS | 13.60 | P/E | 39.53 | Forward P/E | 32.55 |
| Beta | 1.54 | Short Ratio | 3.47 | Inst. Own | 96.06% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 556.12 | 200-d Avg | 628.48 | 1yr Est | 709.14 |
| Income Statement | |||
| Total Revenue | 1.14B | ||
| Revenues (USD) | 1.14B | ||
| Cost of Revenue | 418.08M | ||
| Gross Profit | 722.74M | ||
| Operating Expenses | 360.15M | ||
| Research and Development Expense | 65.79M | ||
| Selling, General and Administrative Expense | 294.37M | ||
| Operating Income | 362.59M | ||
| Interest Expense | 7.74M | ||
| Income Tax Expense | 77.00M | ||
| Net Income | 278.45M | ||
| Net Income Common Stock | 278.45M | ||
| Net Income Common Stock (USD) | 278.45M | ||
| Consolidated Income | 278.45M | ||
| Earnings per Basic Share | 3.50 | ||
| Earnings per Basic Share (USD) | 3.50 | ||
| Earnings per Diluted Share | 3.47 | ||
| Earning Before Interest & Taxes (EBIT) | 363.18M | ||
| Earning Before Interest & Taxes (USD) | 363.18M | ||
| Weighted Average Shares | 79.65M | ||
| Weighted Average Shares Diluted | 80.16M | ||
| Balance Sheet | |||
| Cash and Equivalents | 200.53M | ||
| Cash and Equivalents (USD) | 200.53M | ||
| Trade and Non-Trade Receivables | 603.54M | ||
| Current Assets | 1.45B | ||
| Property, Plant & Equipment Net | 861.78M | ||
| Total Assets | 3.39B | ||
| Debt Current | 680.00M | ||
| Total Debt | 1.08B | ||
| Current Liabilities | 1.30B | ||
| Debt Non-Current | 398.60M | ||
| Total Liabilities | 1.83B | ||
| Accumulated Retained Earnings (Deficit) | 6.67B | ||
| Accumulated Other Comprehensive Income | -64.94M | ||
| Shareholders Equity | 1.56B | ||
| Shareholders Equity (USD) | 1.56B | ||
| Assets Non-Current | 1.93B | ||
| Total Debt (USD) | 1.08B | ||
| Deferred Revenue | 68.64M | ||
| Goodwill and Intangible Assets | 516.85M | ||
| Inventory | 382.40M | ||
| Liabilities Non-Current | 529.54M | ||
| Trade and Non-Trade Payables | 129.97M | ||
| Tax Liabilities | 44.60M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 37.68M | ||
| Net Cash Flow from Financing | -211.43M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 20.46M | ||
| Capital Expenditure | -31.98M | ||
| Issuance (Purchase) of Equity Shares | -332.87M | ||
| Issuance (Repayment) of Debt Securities | 132.00M | ||
| Net Cash Flow from Investing | -33.54M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 240.00K | ||
| Net Cash Flow from Operations | 266.25M | ||
| Effect of Exchange Rate Changes on Cash | -816.00K | ||
| Share Based Compensation | 16.34M | ||